Skip to main content

Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations.

Author
Abstract
:

A poor response to erythropoiesis-stimulating agents such as darbepoetin alfa has been associated with adverse outcomes in patients with diabetes mellitus, chronic kidney disease, and anemia; whether this is also true in heart failure is unclear.

Year of Publication
:
2018
Journal
:
Circulation. Heart failure
Volume
:
11
Issue
:
2
Number of Pages
:
e004431
ISSN Number
:
1941-3289
URL
:
http://circheartfailure.ahajournals.org/cgi/pmidlookup?view=long&pmid=29367268
DOI
:
10.1161/CIRCHEARTFAILURE.117.004431
Short Title
:
Circ Heart Fail
Download citation